Toll Free: 1-888-928-9744
Published: Oct, 2014 | Pages:
1178 | Publisher: Global Markets Direct
Industry: Healthcare | Report Format: Electronic (PDF)
Type 2 Diabetes - Pipeline Review, H2 2014 Summary Global Markets Direct's, 'Type 2 Diabetes - Pipeline Review, H2 2014', provides an overview of the Type 2 Diabetes's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Type 2 Diabetes, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Type 2 Diabetes and special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global therapeutic landscape of Type 2 Diabetes - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Type 2 Diabetes and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Type 2 Diabetes products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Type 2 Diabetes pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Type 2 Diabetes - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Type 2 Diabetes pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Contents Table of Contents 2 Introduction 9 Type 2 Diabetes Overview 10 Therapeutics Development 11 Type 2 Diabetes - Therapeutics under Development by Companies 13 Type 2 Diabetes - Therapeutics under Investigation by Universities/Institutes 31 Type 2 Diabetes - Pipeline Products Glance 33 Type 2 Diabetes - Products under Development by Companies 37 Type 2 Diabetes - Products under Investigation by Universities/Institutes 57 Type 2 Diabetes - Companies Involved in Therapeutics Development 60 Type 2 Diabetes - Therapeutics Assessment 267 Drug Profiles 293 Type 2 Diabetes - Recent Pipeline Updates 986 Type 2 Diabetes - Dormant Projects 1095 Type 2 Diabetes - Discontinued Products 1106 Type 2 Diabetes - Product Development Milestones 1111 Appendix 1119
List of Tables Number of Products under Development for Type 2 Diabetes, H2 2014 69 Number of Products under Development for Type 2 Diabetes - Comparative Analysis, H2 2014 70 Number of Products under Development by Companies, H2 2014 72 Number of Products under Development by Companies, H2 2014 (Contd..1) 73 Number of Products under Development by Companies, H2 2014 (Contd..2) 74 Number of Products under Development by Companies, H2 2014 (Contd..3) 75 Number of Products under Development by Companies, H2 2014 (Contd..4) 76 Number of Products under Development by Companies, H2 2014 (Contd..5) 77 Number of Products under Development by Companies, H2 2014 (Contd..6) 78 Number of Products under Development by Companies, H2 2014 (Contd..7) 79 Number of Products under Development by Companies, H2 2014 (Contd..8) 80 Number of Products under Development by Companies, H2 2014 (Contd..9) 81 Number of Products under Development by Companies, H2 2014 (Contd..10) 82 Number of Products under Development by Companies, H2 2014 (Contd..11) 83 Number of Products under Development by Companies, H2 2014 (Contd..12) 84 Number of Products under Development by Companies, H2 2014 (Contd..13) 85 Number of Products under Development by Companies, H2 2014 (Contd..14) 86 Number of Products under Development by Companies, H2 2014 (Contd..15) 87 Number of Products under Development by Companies, H2 2014 (Contd..16) 88 Number of Products under Investigation by Universities/Institutes, H2 2014 89 Comparative Analysis by Late Stage Development, H2 2014 91 Comparative Analysis by Clinical Stage Development, H2 2014 92 Comparative Analysis by Early Stage Development, H2 2014 93 Comparative Analysis by Unknown Stage Development, H2 2014 94 Products under Development by Companies, H2 2014 95 Products under Investigation by Universities/Institutes, H2 2014 115 Type 2 Diabetes - Pipeline by ActogeniX NV, H2 2014 118 Type 2 Diabetes - Pipeline by Addex Therapeutics Ltd, H2 2014 119 Type 2 Diabetes - Pipeline by Adocia, H2 2014 120 Type 2 Diabetes - Pipeline by Advinus Therapeutics Ltd., H2 2014 121 Type 2 Diabetes - Pipeline by Aegis Therapeutics, LLC, H2 2014 122 Type 2 Diabetes - Pipeline by AFFiRiS AG, H2 2014 123 Type 2 Diabetes - Pipeline by AlbireoPharma, H2 2014 124 Type 2 Diabetes - Pipeline by Alchemia Limited, H2 2014 125 Type 2 Diabetes - Pipeline by Alize Pharma SAS, H2 2014 126 Type 2 Diabetes - Pipeline by Allozyne, Inc., H2 2014 127 Type 2 Diabetes - Pipeline by Ambrx, Inc., H2 2014 128 Type 2 Diabetes - Pipeline by Amgen Inc., H2 2014 129 Type 2 Diabetes - Pipeline by Anchor Therapeutics, Inc., H2 2014 130 Type 2 Diabetes - Pipeline by AntriaBio, Inc., H2 2014 131 Type 2 Diabetes - Pipeline by Aphios Corporation, H2 2014 132 Type 2 Diabetes - Pipeline by Ardelyx, Inc., H2 2014 133 Type 2 Diabetes - Pipeline by Arena Pharmaceuticals, Inc., H2 2014 134 Type 2 Diabetes - Pipeline by Arisaph Pharmaceuticals, Inc., H2 2014 135 Type 2 Diabetes - Pipeline by Array BioPharma Inc., H2 2014 136 Type 2 Diabetes - Pipeline by Arrien Pharmaceuticals, LLC, H2 2014 137 Type 2 Diabetes - Pipeline by Artery Therapeutics, Inc., H2 2014 138 Type 2 Diabetes - Pipeline by Astellas Pharma Inc., H2 2014 139 Type 2 Diabetes - Pipeline by AstraZeneca PLC, H2 2014 140 Type 2 Diabetes - Pipeline by AUS Bio Limited, H2 2014 141 Type 2 Diabetes - Pipeline by Avaxia Biologics, Inc., H2 2014 142 Type 2 Diabetes - Pipeline by Bayer AG, H2 2014 143 Type 2 Diabetes - Pipeline by Betagenon AB, H2 2014 144 Type 2 Diabetes - Pipeline by Biocon Limited, H2 2014 145 Type 2 Diabetes - Pipeline by Biodel Inc., H2 2014 146 Type 2 Diabetes - Pipeline by Biogenomics Limited, H2 2014 147 Type 2 Diabetes - Pipeline by BioTherapeutics Inc., H2 2014 148 Type 2 Diabetes - Pipeline by Boehringer Ingelheim GmbH, H2 2014 149 Type 2 Diabetes - Pipeline by Boston Therapeutics, Inc., H2 2014 150 Type 2 Diabetes - Pipeline by Braasch Biotech LLC, H2 2014 151 Type 2 Diabetes - Pipeline by Bridge Bioresearch Plc, H2 2014 152 Type 2 Diabetes - Pipeline by Bristol-Myers Squibb Company, H2 2014 153 Type 2 Diabetes - Pipeline by Camurus AB, H2 2014 154 Type 2 Diabetes - Pipeline by Cardax Pharmaceuticals, Inc., H2 2014 155 Type 2 Diabetes - Pipeline by Cardiolynx AG, H2 2014 156 Type 2 Diabetes - Pipeline by Carmot Therapeutics, Inc., H2 2014 157 Type 2 Diabetes - Pipeline by Celladon Corporation, H2 2014 158 Type 2 Diabetes - Pipeline by Celon Pharma Sp. z o.o., H2 2014 159 Type 2 Diabetes - Pipeline by ChemoCentryx, Inc., H2 2014 160 Type 2 Diabetes - Pipeline by Chipscreen Biosciences Ltd, H2 2014 161 Type 2 Diabetes - Pipeline by CJ CheilJedang Corp., H2 2014 162 Type 2 Diabetes - Pipeline by Connexios Life Sciences Pvt. Ltd., H2 2014 163 Type 2 Diabetes - Pipeline by Cortendo AB, H2 2014 164 Type 2 Diabetes - Pipeline by CSL Limited, H2 2014 165 Type 2 Diabetes - Pipeline by CTI BioPharma Corp., H2 2014 166 Type 2 Diabetes - Pipeline by CureDM, Inc., H2 2014 167 Type 2 Diabetes - Pipeline by CymaBay Therapeutics, Inc., H2 2014 168 Type 2 Diabetes - Pipeline by Daiichi Sankyo Company, Limited, H2 2014 169 Type 2 Diabetes - Pipeline by Debiopharm International S.A., H2 2014 170 Type 2 Diabetes - Pipeline by Diabetology Limited, H2 2014 171 Type 2 Diabetes - Pipeline by DiaMedica Inc., H2 2014 172 Type 2 Diabetes - Pipeline by Diasome Pharmaceuticals, Inc., H2 2014 173 Type 2 Diabetes - Pipeline by DiscoveryBiomed, Inc., H2 2014 174 Type 2 Diabetes - Pipeline by Dong-A Socio Group, H2 2014 175 Type 2 Diabetes - Pipeline by Eisai Co., Ltd., H2 2014 176 Type 2 Diabetes - Pipeline by Elcelyx Therapeutics, Inc., H2 2014 177 Type 2 Diabetes - Pipeline by Eli Lilly and Company, H2 2014 178 Type 2 Diabetes - Pipeline by Enzo Biochem, Inc., H2 2014 179 Type 2 Diabetes - Pipeline by Esperion Therapeutics, Inc., H2 2014 180 Type 2 Diabetes - Pipeline by Evotec AG, H2 2014 181 Type 2 Diabetes - Pipeline by Exsulin Corporation, H2 2014 182 Type 2 Diabetes - Pipeline by Extrawell Pharmaceutical Holdings Limited, H2 2014 183 Type 2 Diabetes - Pipeline by F. Hoffmann-La Roche Ltd., H2 2014 184 Type 2 Diabetes - Pipeline by Flamel Technologies S.A., H2 2014 185 Type 2 Diabetes - Pipeline by Foresee Pharmaceuticals, LLC, H2 2014 186 Type 2 Diabetes - Pipeline by Generex Biotechnology Corporation, H2 2014 187 Type 2 Diabetes - Pipeline by Genfit SA, H2 2014 188 Type 2 Diabetes - Pipeline by Genovate Biotechnology Co., LTD., H2 2014 189 Type 2 Diabetes - Pipeline by Gilead Sciences, Inc., H2 2014 190 Type 2 Diabetes - Pipeline by GlaxoSmithKline plc, H2 2014 191 Type 2 Diabetes - Pipeline by Glucox Biotech AB, H2 2014 192 Type 2 Diabetes - Pipeline by GW Pharmaceuticals plc, H2 2014 193 Type 2 Diabetes - Pipeline by Hadasit Medical Research Services & Development Ltd, H2 2014 194 Type 2 Diabetes - Pipeline by Halozyme Therapeutics, Inc., H2 2014 195 Type 2 Diabetes - Pipeline by HanAll Biopharma Co., Ltd., H2 2014 196 Type 2 Diabetes - Pipeline by Handok Inc., H2 2014 197 Type 2 Diabetes - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H2 2014 198 Type 2 Diabetes - Pipeline by Harbor Therapeutics, Inc., H2 2014 199 Type 2 Diabetes - Pipeline by Heptares Therapeutics Ltd., H2 2014 200 Type 2 Diabetes - Pipeline by High Point Pharmaceuticals, LLC, H2 2014 201 Type 2 Diabetes - Pipeline by Hua Medicine Ltd., H2 2014 202 Type 2 Diabetes - Pipeline by Hybrigenics S.A., H2 2014 203 Type 2 Diabetes - Pipeline by Hyundai Pharmaceutical Co., Ltd., H2 2014 204 Type 2 Diabetes - Pipeline by Insusense Therapeutics ApS, H2 2014 205 Type 2 Diabetes - Pipeline by Intarcia Therapeutics, Inc., H2 2014 206 Type 2 Diabetes - Pipeline by Integral Molecular, Inc., H2 2014 207 Type 2 Diabetes - Pipeline by InteKrin Therapeutics, Inc., H2 2014 208 Type 2 Diabetes - Pipeline by Intercept Pharmaceuticals, Inc., H2 2014 209 Type 2 Diabetes - Pipeline by IPCA Laboratories Limited, H2 2014 210 Type 2 Diabetes - Pipeline by Isis Pharmaceuticals, Inc., H2 2014 211 Type 2 Diabetes - Pipeline by Islet Sciences, Inc., H2 2014 212 Type 2 Diabetes - Pipeline by iTherX, Inc., H2 2014 213 Type 2 Diabetes - Pipeline by Janssen Research & Development, LLC, H2 2014 214 Type 2 Diabetes - Pipeline by Japan Tobacco Inc., H2 2014 215 Type 2 Diabetes - Pipeline by Jenrin Discovery, Inc., H2 2014 216 Type 2 Diabetes - Pipeline by Jiangsu Hengrui Medicine Co., Ltd., H2 2014 217 Type 2 Diabetes - Pipeline by Johnson & Johnson, H2 2014 218 Type 2 Diabetes - Pipeline by Kadmon Corporation, LLC, H2 2014 219 Type 2 Diabetes - Pipeline by Kareus Therapeutics, SA, H2 2014 220 Type 2 Diabetes - Pipeline by Kissei Pharmaceutical Co., Ltd., H2 2014 221 Type 2 Diabetes - Pipeline by Lexicon Pharmaceuticals, Inc., H2 2014 222 Type 2 Diabetes - Pipeline by LG Life Sciences, Ltd., H2 2014 223 Type 2 Diabetes - Pipeline by Ligand Pharmaceuticals, Inc., H2 2014 224 Type 2 Diabetes - Pipeline by Longevity Biotech, Inc, H2 2014 225 Type 2 Diabetes - Pipeline by Medesis Pharma S.A., H2 2014 226 Type 2 Diabetes - Pipeline by Medestea Research & Production S.p.A., H2 2014 227 Type 2 Diabetes - Pipeline by MedImmune, LLC, H2 2014 228 Type 2 Diabetes - Pipeline by Merck & Co., Inc., H2 2014 229 Type 2 Diabetes - Pipeline by Merck KGaA, H2 2014 230 Type 2 Diabetes - Pipeline by Mesoblast Limited, H2 2014 231 Type 2 Diabetes - Pipeline by Metabolic Solutions Development Company, LLC, H2 2014 232 Type 2 Diabetes - Pipeline by Metabolys S.A.S., H2 2014 233 Type 2 Diabetes - Pipeline by MI.TO. Technology S.r.L., H2 2014 234 Type 2 Diabetes - Pipeline by MidaSol Therapeutics LP, H2 2014 235 Type 2 Diabetes - Pipeline by Mitsubishi Pharmaceutical Corporation, H2 2014 236 Type 2 Diabetes - Pipeline by Mitsubishi Tanabe Pharma Corporation, H2 2014 237 Type 2 Diabetes - Pipeline by Mochida Pharmaceutical Co., Ltd., H2 2014 238 Type 2 Diabetes - Pipeline by NasVax Ltd., H2 2014 239 Type 2 Diabetes - Pipeline by NeoPharm Co., Ltd., H2 2014 240 Type 2 Diabetes - Pipeline by Neurocrine Biosciences, Inc., H2 2014 241 Type 2 Diabetes - Pipeline by NGM Biopharmaceuticals, Inc., H2 2014 242 Type 2 Diabetes - Pipeline by Nordic Bioscience a/s, H2 2014 243 Type 2 Diabetes - Pipeline by Novartis AG, H2 2014 244 Type 2 Diabetes - Pipeline by Novo Nordisk A/S, H2 2014 246 Type 2 Diabetes - Pipeline by Noxxon Pharma AG, H2 2014 247 Type 2 Diabetes - Pipeline by Omeros Corporation, H2 2014 248 Type 2 Diabetes - Pipeline by OPKO Health, Inc., H2 2014 249 Type 2 Diabetes - Pipeline by Oramed Pharmaceuticals, Inc., H2 2014 250 Type 2 Diabetes - Pipeline by Orbis Biosciences, Inc., H2 2014 251 Type 2 Diabetes - Pipeline by Orchid Chemicals & Pharmaceuticals Ltd, H2 2014 252 Type 2 Diabetes - Pipeline by Orgenesis, Inc., H2 2014 253 Type 2 Diabetes - Pipeline by P2D Bioscience, H2 2014 254 Type 2 Diabetes - Pipeline by Panacea Biotec Limited, H2 2014 255 Type 2 Diabetes - Pipeline by Paras Biopharmaceuticals Finland Oy, H2 2014 256 Type 2 Diabetes - Pipeline by Peptron, Inc., H2 2014 257 Type 2 Diabetes - Pipeline by Pfizer Inc., H2 2014 258 Type 2 Diabetes - Pipeline by PharmaIN Corporation, H2 2014 259 Type 2 Diabetes - Pipeline by Pharnext SAS, H2 2014 260 Type 2 Diabetes - Pipeline by PhaseBio Pharmaceuticals, Inc., H2 2014 261 Type 2 Diabetes - Pipeline by Piramal Enterprises Limited, H2 2014 262 Type 2 Diabetes - Pipeline by PlasmaTech Biopharmaceuticals, Inc., H2 2014 263 Type 2 Diabetes - Pipeline by Poxel SA, H2 2014 264 Type 2 Diabetes - Pipeline by Progen Pharmaceuticals Limited, H2 2014 265 Type 2 Diabetes - Pipeline by ProteoTech, Inc., H2 2014 266 Type 2 Diabetes - Pipeline by Prothena Corporation plc, H2 2014 267 Type 2 Diabetes - Pipeline by Ranbaxy Laboratories Limited, H2 2014 268 Type 2 Diabetes - Pipeline by Receptos, Inc., H2 2014 269 Type 2 Diabetes - Pipeline by Regulus Therapeutics Inc., H2 2014 270 Type 2 Diabetes - Pipeline by Relypsa, Inc., H2 2014 271 Type 2 Diabetes - Pipeline by reMYND, H2 2014 272 Type 2 Diabetes - Pipeline by Revivicor, Inc., H2 2014 273 Type 2 Diabetes - Pipeline by Rhizen Pharmaceuticals SA, H2 2014 274 Type 2 Diabetes - Pipeline by Sanofi, H2 2014 275 Type 2 Diabetes - Pipeline by Sanwa Kagaku Kenkyusho Co., Ltd., H2 2014 276 Type 2 Diabetes - Pipeline by SBI Pharmaceuticals Co., Ltd., H2 2014 277 Type 2 Diabetes - Pipeline by Serodus ASA, H2 2014 278 Type 2 Diabetes - Pipeline by Serometrix, LLC, H2 2014 279 Type 2 Diabetes - Pipeline by Shanghai Fosun Pharmaceutical (Group) Co., Ltd., H2 2014 280 Type 2 Diabetes - Pipeline by Shanghai Pharmaceutical Co., Ltd., H2 2014 281 Type 2 Diabetes - Pipeline by Shantani Proteome Analytics Pvt. Ltd., H2 2014 282 Type 2 Diabetes - Pipeline by Shionogi & Co., Ltd., H2 2014 283 Type 2 Diabetes - Pipeline by SignPath Pharma Inc, H2 2014 284 Type 2 Diabetes - Pipeline by Sihuan Pharmaceutical Holdings Group Ltd., H2 2014 285 Type 2 Diabetes - Pipeline by Sirona Biochem Corp, H2 2014 286 Type 2 Diabetes - Pipeline by SK Chemicals Co., Ltd., H2 2014 287 Type 2 Diabetes - Pipeline by Starpharma Holdings Limited, H2 2014 288 Type 2 Diabetes - Pipeline by Stelic Institute & Co., H2 2014 289 Type 2 Diabetes - Pipeline by Stempeutics Research Private Limited, H2 2014 290 Type 2 Diabetes - Pipeline by Sumitomo Dainippon Pharma Co., Ltd., H2 2014 291 Type 2 Diabetes - Pipeline by Summit Corporation plc, H2 2014 292 Type 2 Diabetes - Pipeline by Synthetic Biologics, Inc., H2 2014 293 Type 2 Diabetes - Pipeline by Taisho Pharmaceutical Co., Ltd., H2 2014 294 Type 2 Diabetes - Pipeline by Takeda Pharmaceutical Company Limited, H2 2014 295 Type 2 Diabetes - Pipeline by Teijin Pharma Limited, H2 2014 296 Type 2 Diabetes - Pipeline by Teva Pharmaceutical Industries Limited, H2 2014 297 Type 2 Diabetes - Pipeline by Theracos, Inc., H2 2014 298 Type 2 Diabetes - Pipeline by Thermalin Diabetes, LLC, H2 2014 299 Type 2 Diabetes - Pipeline by Thetis Pharmaceuticals LLC, H2 2014 300 Type 2 Diabetes - Pipeline by Toray Industries, Inc., H2 2014 301 Type 2 Diabetes - Pipeline by Torrent Pharmaceuticals Limited, H2 2014 302 Type 2 Diabetes - Pipeline by Transgene Biotek Limited, H2 2014 303 Type 2 Diabetes - Pipeline by Transition Therapeutics Inc., H2 2014 304 Type 2 Diabetes - Pipeline by TransTech Pharma, Inc., H2 2014 305 Type 2 Diabetes - Pipeline by TWi Pharmaceuticals, Inc., H2 2014 306 Type 2 Diabetes - Pipeline by Uni-Bio Science Group Ltd., H2 2014 307 Type 2 Diabetes - Pipeline by Upsher-Smith Laboratories, Inc., H2 2014 308 Type 2 Diabetes - Pipeline by Versartis, Inc., H2 2014 309 Type 2 Diabetes - Pipeline by Verva Pharmaceuticals Limited, H2 2014 310 Type 2 Diabetes - Pipeline by Vicore Pharma AB, H2 2014 311 Type 2 Diabetes - Pipeline by Virobay Inc., H2 2014 312 Type 2 Diabetes - Pipeline by Vitae Pharmaceuticals, Inc., H2 2014 313 Type 2 Diabetes - Pipeline by Vybion, Inc., H2 2014 314 Type 2 Diabetes - Pipeline by X-BODY BioSciences, Inc., H2 2014 315 Type 2 Diabetes - Pipeline by XBiotech USA, Inc., H2 2014 316 Type 2 Diabetes - Pipeline by Xenetic Biosciences plc, H2 2014 317 Type 2 Diabetes - Pipeline by XL-protein GmbH, H2 2014 318 Type 2 Diabetes - Pipeline by XOMA Corporation, H2 2014 319 Type 2 Diabetes - Pipeline by XORTX Pharma Corp., H2 2014 320 Type 2 Diabetes - Pipeline by Yuhan Corporation, H2 2014 321 Type 2 Diabetes - Pipeline by Zafgen Inc., H2 2014 322 Type 2 Diabetes - Pipeline by Zealand Pharma A/S, H2 2014 323 Type 2 Diabetes - Pipeline by Zydus Cadila Healthcare Limited, H2 2014 324 Assessment by Monotherapy Products, H2 2014 325 Assessment by Combination Products, H2 2014 326 Number of Products by Stage and Target, H2 2014 328 Number of Products by Stage and Mechanism of Action, H2 2014 338 Number of Products by Stage and Route of Administration, H2 2014 348 Number of Products by Stage and Molecule Type, H2 2014 350 Type 2 Diabetes Therapeutics - Recent Pipeline Updates, H2 2014 1044 Type 2 Diabetes - Dormant Projects, H2 2014 1153 Type 2 Diabetes - Discontinued Products, H2 2014 1164
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.